In a systematic review of treatments for autism spectrum disorders, oxytocin received a Grade B recommendation (supported by at least one prospective RCT or two nonrandomized controlled trials).
In plain wordsA review of autism treatments gave oxytocin a Grade B rating, which needs at least one randomized trial or two non-randomized controlled trials.
- Peptide
- Oxytocin
- Outcome
- Not applicableEvidence grade of oxytocin for autism spectrum disorders
- Study
n: not reported in source
- Outcome group
- Overall treatment effect · Mental health and mood
- Studied dose
- Dose not stated
Source sentences
Grade B treatments include carnitine, tetrahydrobiopterin, vitamin C, alpha-2 adrenergic agonists, hyperbaric oxygen treatment, immunomodulation and anti-inflammatory treatments, oxytocin, and vision therapy.
2 context sentences(design, population, supporting numbers)
A grade of recommendation ("Grade") was then assigned to each treatment using a validated evidence-based guideline as outlined in this review: A: Supported by at least 2 prospective randomized controlled trials (RCTs) or 1 systematic review.
B: Supported by at least 1 prospective RCT or 2 nonrandomized controlled trials.